JHJohn E. Herrmann

John E. Herrmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John E. Herrmann has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Abraham L. Sonenshein

    Department of Biomedical Sciences, Tufts University, Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536,1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111,2 Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112,3 Department of International Health, Boston University School of Public Health, Boston, Massachusetts 021184

    1 shared publication
  • Boris R. Belitsky

    Department of Biomedical Sciences, Tufts University, Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536,1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111,2 Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112,3 Department of International Health, Boston University School of Public Health, Boston, Massachusetts 021184

    1 shared publication
  • David W. Brown

    Department of Biomedical Sciences, Tufts University, Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536,1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111,2 Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112,3 Department of International Health, Boston University School of Public Health, Boston, Massachusetts 021184

    1 shared publication
  • Gerald T. Keusch

    Department of Biomedical Sciences, Tufts University, Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536,1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111,2 Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112,3 Department of International Health, Boston University School of Public Health, Boston, Massachusetts 021184

    1 shared publication
  • James P. Brinker

    Department of Biomedical Sciences, Tufts University, Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536,1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111,2 Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112,3 Department of International Health, Boston University School of Public Health, Boston, Massachusetts 021184

    1 shared publication
  • John D. Clements

    Department of Biomedical Sciences, Tufts University, Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536,1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111,2 Department of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112,3 Department of International Health, Boston University School of Public Health, Boston, Massachusetts 021184

    1 shared publication

Latest Publications

  • Open Access

    Development of a Bacillus subtilis -Based Rotavirus Vaccine

    by Sangun Lee, Boris R. Belitsky, James P. Brinker, Kathryn O. Kerstein, David W. Brown, John D. Clements, Gerald T. Keusch, Saul Tzipori, Abraham L. Sonenshein, John E. Herrmann

    Bacillus subtilis vaccine strains engineered to express either group A bovine or murine rotavirus VP6 were tested in adult mice for their ability to induce immune responses and provide protection against rotavirus challenge. Mice were inoculated intranasally with spores or vegetative cells of the recombinant strains of B. subtilis . To enhance mucosal immunity, whole cholera toxin (CT) or a mutant form (R192G) of Escherichia coli heat-labile toxin (mLT) were included as adjuvants. To evaluate vaccine efficacy, the immunized mice were challenged orally with EDIM EW murine rotavirus and monitored daily for 7 days for virus shedding in feces. Mice immunized with either VP6 spore or VP6 vegetative cell vaccines raised serum anti-VP6 IgG enzyme-linked immunosorbent assay (ELISA) titers, whereas only the VP6 spore vaccines generated fecal anti-VP6 IgA ELISA titers. Mice in groups that were immunized with VP6 spore vaccines plus CT or mLT showed significant reductions in virus shedding, whereas the groups of mice immunized with VP6 vegetative cell vaccines showed no difference in virus shedding compared with mice immunized with control spores or cells. These results demonstrate that intranasal inoculation with B. subtilis spore-based rotavirus vaccines is effective in generating protective immunity against rotavirus challenge in mice.


  • DNA vaccines against enteric infections

    by John E. Herrmann